Warning

This page includes the current referral guidelines and pathways for the management of patients referred with a suspicion of Breast cancer, including highlighting which elements of the pathway will be provided locally by NHS Borders, and which will require to be undertaken in NHS Lothian (Tertiary services).

Patients referred as Urgent with Suspicion of Cancer will be tracked against the Breast Cancer pathway. All patients referred this way will receive a contact from Single Point of Contact (SPOC), it is important that patients are made aware of their USoC referral.

The Breast cancer service is provided by:

  • Mr Shareef Al-Sabounchi, Consultant Breast Surgeon and Tumour Site Lead
  • Dr Apu Sinha, Consultant Radiologist
  • Miss Dominique Twelves, Consultant Breast Surgeon
  • Dr Ben Ward, Consultant Radiologist
  • Fiona Ainslie, Cancer Nurse Specialist
  • Fiona Balmer, Senior Radiographer
  • Caroline Renwick, Lead Cancer Specialist

Guidance about referral to regional genetics centres for those with a family history of breast cancer is available at: South East Scotland Genetic Service breast cancer family history

Breast cancer is the most common (non-skin) cancer in women in Scotland, with around 5,140 new cases each year. Breast cancer is much less likely in men, with approximately 40 cases per year in Scotland. Incidence rises from age 30 in women (more than 99.5% of new cases are aged 30 years or over) and from age 45 in men (more than 90% of new cases are aged 45 or over).

Most breast cancers are diagnosed at an early stage (1 or 2). In 2022, 38.0% of cases were diagnosed at stage 1, 46.5% at stage 2, 8.4% at stage 3, 4.8% at stage 4, and 2.2% were diagnosed at an unknown stage in Scotland. Women diagnosed at an earlier stage may have an improved chance of survival. Stage distribution differs by deprivation, with women living in more deprived areas being more likely to experience an advanced stage breast cancer diagnosis.

There are several risk factors for breast cancer, including:

  • Significant family history of breast cancer (see good practice section) or an inherited genetic alteration
  • A previous diagnosis of breast cancer
  • Early menarche (before age 11)
  • Oral contraceptive use or hormone replacement therapy
  • Older age at first giving birth (35 years or over)
  • Nulliparity
  • Not breastfeeding
  • Older age at menopause (50 years or over)
  • The risk of breast cancer is also two to four times higher in women with previous false positive breast screening results.

Published data has shown that transgender women have a higher risk of breast cancer compared to men, and transgender men have a lower risk of breast cancer compared to women. In transgender women the risk of breast cancer is associated with hormone treatment. In cases of gender reassignment, it is important to provide sensitive and clinically appropriate care depending on individual circumstances and considering any hormone therapy involved.

Help-seeking behaviours and awareness of symptoms varies by demographic. There is evidence suggesting that first-generation Black African and Black Caribbean women in the UK who were diagnosed with symptomatic breast cancer had lower symptom awareness and faced barriers which resulted in delayed help-seeking.

Who to refer, who not to refer, how to refer

Breast Cancer: Urgent Suspicion of Cancer Referral Criteria:

Patients presenting with symptoms below should be referred to the Breast service urgently as a Suspicion of Cancer:

Lump:

  • New breast lump in a person aged 30 years or over
  • New breast lump in a person aged under 30 who also has other suspicious features such as an axillary lump, nipple or skin changes (as below) or a significant family history of breast cancer (see Regional Genetics Centres)
  • New, unexplained axillary lump (2cm or more in size, persisting for 6 weeks or more, or increasing in size)

Nipple changes:

  • Nipple discharge that is serosanguinous (clear yellow liquid with or without red blood staining)
  • New, unilateral, and non-reversible nipple retraction
  • Unilateral nipple eczema that is unresponsive to a two-week treatment with moderately potent topical steroids

Skin changes:

  • Skin tethering
  • Peau d’orange
  • Unexplained, new breast ulceration

Inflammation:

  • Mastitis or breast inflammation that does not settle or recurs after one course of antibiotics

Assessment of suspected breast cancer

Breast cancer is characterised by a narrow symptom signature, meaning that most people present with only a few specific symptoms such as a breast lump and typically have short diagnostic intervals.

Assessment of a person presenting with breast symptoms or signs should include examination to determine if any lump (discrete, palpable abnormality) or lesion (any abnormal tissue change) is within the breast tissue, or related to the skin and if there are any associated axillary lumps. If there is an axillary lump without other breast findings, examination for other lymphadenopathy should be performed.

It is helpful to document if any nipple discharge is spontaneous or expressed, is from a single duct, multiple ducts or bilateral and if there is any blood staining. It is also helpful to note if any nipple inversion is fixed or reversible.

Any pain should be assessed to determine if it is coming from the breast or the chest wall.

Ask about any family history of breast cancer or other cancers related to inherited genetic alterations (e.g. ovarian cancer). Also ask about past medical history including menopausal status, previous chest radiotherapy, and mammography or breast screening results, as patients with false-positive results have a higher risk of developing breast cancer.

Routine Referral Criteria: The undernoted symptoms are not suggestive of cancer, patients presenting with these should be referred as routine:

Breast lump:

Consider a non-USC referral for a person with:

  • New asymmetrical breast nodularity (generalised unevenness or thickened areas rather than a discrete lump) that persists for three weeks or more
  • A new breast lump under 30 years of age but with no other suspicious features (described above under USC referral)

Infection:

  • An acute breast abscess requires immediate discussion with the breast team or on-call surgical team for management.

Male breast cancer:

  • Breast cancer is much less common in men than women. Most men are diagnosed over the age of 60. It can be confused with gynaecomastia. Gynaecomastia is a benign enlargement of the male breast with firm tissue extending concentrically beyond the nipple. It may present as unilateral, bilateral, painful, or asymptomatic. If a man presents with a new breast lump (not generalised breast tissue swelling or a skin lesion close to the breast) or other suspicious features as described above, they should be referred as a USC.

Breast pain:

  • Breast pain alone (no associated suspicious features described above under USC referral), is not associated with breast cancer – see CfSD pathway.

Skin and nipple changes:

  • Skin and nipple changes are common breast symptoms. Suspicious changes described above should be referred as a USC. Available guidelines on Right Decision Service (RDS) should be followed for other skin or nipple changes.

Axillary lumps:

  • Breast cancer rarely presents with axillary nodes alone. Consider other malignant or non-cancer causes of lymphadenopathy such as, connective tissue disease, eczema and HIV infection. Consider other causes of axillary lumps, for example, skin lesions or accessory breast tissue.
  • If axillary lymph node(s) are persisting with no obvious cause, the patient should be referred to secondary care. Further guidance on assessment of lymphadenopathy can be found in the Haematological cancer referral guideline.

Breast implants:

  • In the context of breast implants, it is important to determine if the issue being described relates to the implant or the overlying breast tissue. If there is an implant issue rather than a breast issue, then please refer to the service that first inserted the implant (usually plastic surgery) or follow your local pathway.

Family history:

  • A family history of breast cancer increases the risk of developing breast cancer, however most women diagnosed will not have a family history. See Regional Genetics Centres for advice on referral.

Recurrence of primary breast cancer:

  • Recurrence is when breast cancer has come back, it is not a new breast cancer. If a patient has been discharged from follow-up they may present in primary care. For recurrence symptoms see the Breast clinical management pathway.

Metastatic breast cancer:

  • Metastatic or secondary breast cancer is when breast cancer spreads to other parts of the body, such as the bones, liver, lungs or brain. For metastatic breast cancer symptoms please see the Breast clinical management pathway and refer to the Non-Specific Cancer Referral Guideline.

Access CfSD clinical management guidelines for a range of breast symptoms, including breast pain.

Primary care management

Patients presenting with the undernoted symptoms should be managed in Primary Care:

Lumps

  • Women with longstanding tender lumpy breasts and no focal lesion
  • Tender developing breasts in adolescents

Nipple Symptoms

Skin Changes

  • Obvious simple skin lesions such as epidermoid (sebaceous) cysts

Abscess / Infection

  • Abscess or inflammation - try one course of antibiotics
  • Any acute abscess requires immediate discussion with secondary care

Breast Pain

  • Women with moderate degrees of breast pain and no discrete palpable lesion
  • Please see Breast Pain pathway

Gynaecomastia

  • Review & examine to exclude lymphadenopathy or evidence endocrine condition with blood tests
  • Review to exclude drug causes
  • Please see Gynaecomastia pathway for primary care management

Breast Implants

  • Reassurance is often appropriate if symptoms relate to the implant alone and not to underlying breast tissue

Resources and links

National and local websites for further information 

Breast Cancer - Scottish referral guidelines for suspected cancer

Relevant breast family history

  • One first degree female relative diagnosed with breast cancer under the age of 40 (a first degree relative i.e a parent, brother or sister)
  • History of one first degree male relative diagnosed with breast cancer at any age
  • One first degree relative with Bilateral breast cancer where the first cancer was diagnosed aged younger than 50
  • Two first degree relatives, or one first degree and one second degree relative, diagnosed with breast cancer at any age (second degree relatives e.g aunts, uncles, nephews, nieces, grandparents, and grandchildren)
  • One first degree or second degree relative diagnosed with breast cancer at any age and one first degree or second degree relative diagnosed with ovarian cancer at any age (one of these should be a first degree relative)
  • Three first degree or second-degree relatives diagnosed with breast cancer at any age

Local service details

BOR.BreastCancerClinicalNurseSpecialists@borders.scot.nhs.uk

Editorial Information

Last reviewed: 31/12/2025

Next review date: 31/12/2028

Author(s): Mr Shareef Al-Sabounchi.

Author email(s): Shareef.alsabounchi@borders.scot.nhs.uk.